ONXEO (EPA:ALONX) | Finanzwire

Basculer en Français

9473	Companies
185396	Keywords
117753	Articles
99279	Press releases

Home
Companies
ONXEO

PRESS RELEASE

published on 10/30/2025 at 09:05, 1 month 5 days ago

Half-Year Financial Report 2025
BRIEF

published on 10/30/2025 at 09:03, 1 month 5 days ago

Valerio Therapeutics' financial and strategic review for the first half of 2025

Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
PRESS RELEASE

published on 10/30/2025 at 09:00, 1 month 5 days ago

Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases

Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
BRIEF

published on 03/19/2025 at 15:32, 8 months 16 days ago

Valerio Therapeutics Announces Board Members and Their Roles

Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE

published on 03/19/2025 at 15:27, 8 months 16 days ago

Inside Information / Other news releases
Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025

Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF

published on 03/19/2025 at 12:35, 8 months 16 days ago

Valerio Therapeutics Board Meeting Decisions

Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE

published on 03/19/2025 at 12:30, 8 months 16 days ago

Inside Information / Other news releases
Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers

Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF

published on 02/04/2025 at 10:40, 10 months ago

Valerio Therapeutics opts for strategic refocusing

Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE

published on 02/04/2025 at 10:35, 10 months ago

Inside Information / Other news releases
Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development

Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF

published on 10/01/2024 at 00:56, 1 year 2 months ago

Valerio Therapeutics Reports First Half 2024 Financial Results

Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 11 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 16 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 46 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 41 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 46 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 15 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 16 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 40 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 45 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 45 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 46 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 1 minute ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE